We were delighted to catch up with our Editorial Board member, Prof. Toby Maher (University of Southern California, Los Angeles, CA, USA) during the ERS Virtual Congress, to discuss the ISABELA study in IPF (NCT03711162) and the challenges the trial has faced during the COVID-19 pandemic.
- What are the major unmet needs in the treatment of idiopathic pulmonary fibrosis (IPF)? (0:11)
- Could you tell us a little about ziritaxestat and its mechanism of action? (1:30)
- Could you give us an overview of the ISABELA clinical trial program and its findings to date? (2:28)
- What are the next steps in the clinical development of ziritaxestat? (3:46)
- What are the major challenges of conducting IPF clinical trials in the era of COVID-19? (5:07)
Speaker disclosure: Toby Maher has acted as a consultant and speaker for Boehringer Ingelheim, Galapagos and Roche.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress 2020.
Share this Video
Related Videos In Idiopathic pulmonary fibrosis
Junelle Speller – The Pulmonary Fibrosis Foundation Community Registry
The Pulmonary Fibrosis Foundation (PFF) Registry is collecting data from patients with pulmonary fibrosis (PF) or interstitial lung disease (ILD), lung transplant recipients who have had PF or ILD as well as caregivers and family members of patients to help advance medical research. It was a pleasure to talk with PFF Vice President, Junelle Speller […]
Junelle Speller: Pulmonary Fibrosis Foundation – Unmet Needs in Pulmonary Fibrosis and Interstitial Lung Disease
The Pulmonary Fibrosis Foundation (PFF) Registry is collecting data from patients with pulmonary fibrosis (PF) or interstitial lung disease (ILD), lung transplant recipients who have had PF or ILD as well as caregivers and family members of patients to help advance medical research. touchRESPIRATORY were delighted to talk to PFF Vice President, Junelle Speller around […]
Bill Schmidt: Pulmonary Fibrosis Foundation – Pulmonary Fibrosis Awareness Month
touchRESPIRATORY were delighted to talk with Bill Schmidt, President and CEO of the Pulmonary Fibrosis Foundation (PFF) around the goals of the Pulmonary Fibrosis Awareness Month taking place over September, this year’s theme “Here for Each Other” and the importance of awareness and reducing misconceptions around pulmonary fibrosis. Questions What are the goals of the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!